We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Simple Mouth Rinse Test Provides Early Cardiovascular Disease Warning Signs

By LabMedica International staff writers
Posted on 21 Aug 2023
Print article
Image: A simple mouth rinse could spot early heart disease risk (Photo courtesy of Freepik)
Image: A simple mouth rinse could spot early heart disease risk (Photo courtesy of Freepik)

Periodontitis, a widespread oral health issue involving infected gums, has been linked to cardiovascular disease. In a new study, scientists explored the inflammation leading to periodontitis and examined whether the levels of white blood cells (a sign of gum inflammation) in the saliva of healthy adults could signal potential cardiovascular issues. Specifically, they looked at whether high levels of these cells correlated with compromised flow-mediated dilation, an early sign of arterial problems.

Scientists at Mount Royal University (Calgary, AB, Canada) set out to investigate the link among young adults without any known periodontal problems to see if even minor levels of oral inflammation might have clinical significance for heart health. They selected two measures, pulse-wave velocity (to gauge artery stiffness) and flow-mediated dilation (to assess how well arteries expand to allow increased blood flow), as key indicators of cardiovascular risk. Both of these measurements directly relate to arterial health, and issues with either can increase the risk of heart disease.

The study involved 28 non-smoking participants aged 18 to 30, with no underlying health conditions, medications that might affect cardiovascular risk, or history of periodontal disease. Before visiting the laboratory, they were instructed to fast for six hours, although water intake was allowed. Upon arrival, they rinsed their mouths with water, followed by saline, which was then collected for analysis. Participants subsequently underwent an electrocardiogram while lying down, and remained in that position for additional tests, including blood pressure, flow-mediated dilation, and pulse-wave velocity measurements.

The findings revealed that high levels of white blood cells in the saliva were significantly linked to poor flow-mediated dilation, indicating a heightened risk of cardiovascular disease in these individuals. Interestingly, there was no connection between white blood cells and pulse-wave velocity, suggesting that the long-term effects on artery health were not yet evident. Scientists have proposed that the inflammation from the mouth, possibly seeping into the vascular system, could affect the arteries' ability to produce nitric oxide, which aids in responding to changes in blood flow. Elevated levels of white blood cells might further exacerbate this vascular dysfunction, although the levels detected in the study participants are generally not seen as clinically significant, indicating that even minor inflammation could have broader health implications.

“We are starting to see more relationships between oral health and risk of cardiovascular disease,” said Ker-Yung Hong, first author of the study. “If we are seeing that oral health may have an impact on the risk of developing cardiovascular disease even in young healthy individuals, this holistic approach can be implemented earlier on.”

“The mouth rinse test could be used at your annual checkup at the family doctors or the dentist,” said Dr. Michael Glogauer, a co-author of the study. “It is easy to implement as an oral inflammation measuring tool in any clinic.”

Related Links:
Mount Royal University 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.